PT  - JOURNAL ARTICLE
AU  - Zarifyan, Alla
ED  - Filippatos, Gerasimos
TI  - ARTS-HF Study
DP  - 2015 Nov 21
TA  - MD Conference Express
PG  - 16--16
VI  - 15
IP  - 28
4099  - http://mdc.sagepub.com/content/15/28/16.short
4100  - http://mdc.sagepub.com/content/15/28/16.full
AB  - ARTS-HF study demonstrated that finerenone had a comparable efficacy with eplerenone in reducing N-terminal pro-brain natriuretic peptide and a greater efficacy in reducing the incidence of the composite of all-cause death, cardiovascular hospitalization, or emergency presentation for worsening chronic heart failure in patients with heart failure with reduced ejection fraction and type 2 diabetes or chronic kidney disease. However, caution is required in interpreting the results because it was an exploratory, underpowered study.